Surgical Research Review| Volume 129, ISSUE 5, P517-523, May 2001

Clinical trials of the effectiveness of devices: An analogy with drugs


      Surgery 2001;129:517-23.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Committee for Clinical Review FDA
        Final Report of the Committee for Clinical Review.
        : US Food and Drug Agency, Rockville (MD)1993
        • Coronary Drug Project Research Group
        Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project.
        N Engl J Med. 1980; 303: 1038-1041
        • Gail MH
        • Wiend S
        • Piantodosi S
        Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates.
        Biometrika. 1984; 71: 431-434
        • Lynch CJ
        • Lachenbruch PA
        Statistical issues in biologics submissions to the FDA.
        Drug Information J. 1996; 30: 921-933
        • Little RJA
        • Rubin DB
        Statistical analysis with missing data.
        : John Wiley and Sons, Inc, New York1987
        • Wittes J
        • Lakatos E
        • Probstfield J
        Surrogate endpoints in clinical trials: cardiovascular diseases.
        Stat Med. 1989; 8: 415-425
        • Lakatos E
        Sample size determination in clinical trials with time-dependent rates of losses and noncompliance.
        Control Clin Trials. 1986; 7: 89-99
        • Lachin J
        • Foulkes M
        Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification.
        Biometrics. 1986; 42: 507-519
        • Wu M
        • Fisher M
        • DeMets D
        Sample sizes for long-term medical trial with time-dependent dropout and event rates.
        Control Clin Trials. 1980; 1: 109-121
        • Peduzzi P
        • Wittes J
        • Detre K
        • Holford T
        Analysis as-randomized and the problem of non-adherence: an example from the Veterans Affairs Randomized Trial of Coronary Artery Bypass Surgery.
        Stat Med. 1993; 12: 1185-1195
        • Peduzzi P
        • Detre K
        • Wittes J
        • Holford T
        Intent-to-treat analysis and the problem of crossovers. An example from the Veterans Administration coronary bypass surgery study.
        J Thorac Cardiovasc Surg. 1991; 101: 481-487
        • Benson H
        • McCallie Jr, DP
        Angina pectoris and the placebo effect.
        N Engl J Med. 1979; 300: 1424-1429